Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition (Q34279206)

1 August 2017

title

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition (English)

1 reference

1 August 2017

main subject

Pseudomonas aeruginosa

0 references

multiple drug resistance

1 reference

Eva Morales

1

1 reference

1 August 2017

Francesc Cots

2

1 reference

1 August 2017

Maria Sala

3

1 reference

1 August 2017

Mercè Comas

4

1 reference

1 August 2017

Francesc Belvis

5

1 reference

1 August 2017

Marta Riu

6

1 reference

1 August 2017

Margarita Salvadó

7

1 reference

1 August 2017

Santiago Grau

8

1 reference

1 August 2017

Juan P Horcajada

9

1 reference

1 August 2017

Maria Milagro Montero

10

1 reference

1 August 2017

Xavier Castells

11

1 reference

1 August 2017

publication date

23 May 2012

1 reference

BMC Health Services Research

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

page(s)

122

1 reference

Costs Attributable to Healthcare-Acquired Infection in Hospitalized Adults and a Comparison of Economic Methods

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

The current state of multidrug-resistant gram-negative bacilli in North America

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

Epidemiology of drug resistance: implications for a post-antimicrobial era

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412693

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-12-122

Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-12-122

Investigating DRG cost weights for hospitals in middle income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-12-122

Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-12-122

Nosocomial infection, length of stay, and time-dependent bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-12-122

Risk adjustment: beyond patient classification systems

21 January 2018

1 reference

12 December 2020

Managing the stages of hospital cost accounting

1 reference

12 December 2020

Activity-based costing for hospitals

1 reference

12 December 2020

Consequences of bacterial resistance to antibiotics in medical practice

1 reference

12 December 2020

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

12 December 2020

Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa

1 reference

12 December 2020

The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs

1 reference

12 December 2020

Hospital economic impact of an outbreak of Pseudomonas aeruginosa infections

1 reference

12 December 2020

Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study

1 reference

12 December 2020

Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-12-122

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference